Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony V Serritella

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Oncology|January 30, 2024
Metastatic Hormone-Sensitive Prostate Cancer in the Era of Doublet and Triplet TherapyAnthony V Serritella, Maha Hussain
Current Treatment Options in Oncology|January 25, 2025
Correction to: Metastatic Hormone-Sensitive Prostate Cancer in the Era of Doublet and Triplet TherapyAnthony V Serritella, Maha Hussain
JAMA Oncology|August 31, 2023
Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma: A Meta-AnalysisAnthony V Serritella, Niraj K Shenoy
Thoracic Surgery Clinics|April 25, 2020
Anaplastic Lymphoma Kinase Mutation-Positive Non-Small Cell Lung CancerAnthony V Serritella, Christine M Bestvina
European Urology Focus|January 27, 2023
Intermittent Androgen Deprivation for Biochemically Recurrent Prostate Cancer: First Do No HarmAnthony V Serritella, Sarah E Fenton, Maha Hussain
Schizophrenia Research|November 22, 2015
Implications for reactive oxygen species in schizophrenia pathogenesisMinori Koga, Anthony V Serritella, Akira Sawa, et al.
Clinical Pharmacology and Therapeutics|April 17, 2020
Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking ValueAnthony V Serritella, Garth W Strohbehn, Daniel A Goldstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2024
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate CancerKunal B Desai, Anthony V Serritella, Walter M Stadler, et al.
The Oncologist|January 11, 2024
Large Cell Neuroendocrine Prostate Cancer: Large Is Not SmallAnthony V Serritella, Himisha Beltran, Tamara L Lotan, et al.
Cancer Journal (Sudbury, Mass.)|August 1, 2020
Interventional PharmacoeconomicsDaniel A Goldstein, Garth W Strohbehn, Anthony V Serritella, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Oncology|January 30, 2024
Metastatic Hormone-Sensitive Prostate Cancer in the Era of Doublet and Triplet TherapyAnthony V Serritella, Maha Hussain
Current Treatment Options in Oncology|January 25, 2025
Correction to: Metastatic Hormone-Sensitive Prostate Cancer in the Era of Doublet and Triplet TherapyAnthony V Serritella, Maha Hussain
JAMA Oncology|August 31, 2023
Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma: A Meta-AnalysisAnthony V Serritella, Niraj K Shenoy
Thoracic Surgery Clinics|April 25, 2020
Anaplastic Lymphoma Kinase Mutation-Positive Non-Small Cell Lung CancerAnthony V Serritella, Christine M Bestvina
European Urology Focus|January 27, 2023
Intermittent Androgen Deprivation for Biochemically Recurrent Prostate Cancer: First Do No HarmAnthony V Serritella, Sarah E Fenton, Maha Hussain
Schizophrenia Research|November 22, 2015
Implications for reactive oxygen species in schizophrenia pathogenesisMinori Koga, Anthony V Serritella, Akira Sawa, et al.
Clinical Pharmacology and Therapeutics|April 17, 2020
Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking ValueAnthony V Serritella, Garth W Strohbehn, Daniel A Goldstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2024
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate CancerKunal B Desai, Anthony V Serritella, Walter M Stadler, et al.
The Oncologist|January 11, 2024
Large Cell Neuroendocrine Prostate Cancer: Large Is Not SmallAnthony V Serritella, Himisha Beltran, Tamara L Lotan, et al.
Cancer Journal (Sudbury, Mass.)|August 1, 2020
Interventional PharmacoeconomicsDaniel A Goldstein, Garth W Strohbehn, Anthony V Serritella, et al.
Pageof 3